JNJ's Crucell halts supply of 2.36 mln flu vaccines to Italy
PARIS Oct 17 (Reuters) - Crucell, the vaccines unit of U.S. drugmaker Johnson & Johnson , has suspended a delivery of 2.36 million seasonal flu vaccine doses to Italy after it found problems with two lots of it, the Italian health ministry said on Wednesday.
The ministry said in a statement that the Netherlands-based vaccine maker halted the planned supply of its Inflexal V vaccine after two lots out of 32 failed quality checks.
Crucell was not immediately available for comment.
Italy's flu vaccination campaign will start as planned because health authorities will fill in the shortfall by purchasing more doses from other manufacturers, the statement said.
Italy uses between 10 and 12 million doses of flu vaccines every year, the health ministry said.
- Total CEO de Margerie killed in Moscow as jet hits snow plow |
- Pistorius starts five-year term for killing Reeva Steenkamp |
- Ebola crisis turns a corner as U.S. issues new treatment protocols
- Fashion designer Oscar de la Renta dead at 82 |
- U.S. Congress examining deal between NSA official, ex-agency chief